Maersk Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
About Maersk Pharma
Maersk Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 April 2023 (One year and nine months 18 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shreekant Shetty and Hari Om serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U47721MH2023PTC401781
-
Company No.
401781
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Apr 2023
-
Date of AGM
03 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Who are the key members and board of directors at Maersk Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shreekant Shetty
|
Director | 27-Apr-2023 | Current |
|
Hari Om
|
Director | 27-Apr-2023 | Current |
Financial Performance of Maersk Pharma.
Enhance accessibility to Maersk Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maersk Pharma?
Unlock access to Maersk Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Infallible Pharma Private LimitedShreekant Shetty and Hari Om are mutual person
-
Mckesson & Robbins Private LimitedShreekant Shetty and Hari Om are mutual person
-
Amerisourcebergen Private Limited
Shreekant Shetty and Hari Om are mutual person
-
Sagent Pharmaceuticals Private Limited
Shreekant Shetty and Hari Om are mutual person
-
Bsh Consultancy Private Limited
Shreekant Shetty and Hari Om are mutual person
-
Nitambika Foundation
Hari Om is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Maersk Pharma?
Unlock and access historical data on people associated with Maersk Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maersk Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maersk Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.